WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals
World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , IFSIJ Measure of Journal Quality , Scientific Journal Impact Factor (SJIF) , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , 

ISSN 2457-0400

Impact Factor  :  5.464

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • 6th International Conference on Human and Soci

    Venue:FCT Education Resource Center, Abuja- Nigeria                                        September 22-24, 2019

  • WJAHR New Impact Factor

    Its our Pleasure to Inform you that WJAHR Impact Factor has been increased from  4.897 to 5.464 due to high quality Publication at International Level

  • .

    6th INTERNATIONAL CONFERENCE ON EDUCATIONAL TECHNOLOGY AND CURRICULUM STUDIES(ICETC2019) 

     

    Venue: FCT Education Resource Center, Abuja-Nigeria

    September 22-24, 2019

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR 1 January 2021 Issue has been Published, Kindly check it on http://www.wjahr.com/home/current_issues

  • WJAHR JANUARY ISSUE PUBLISHED

    JANUARY 2021 Issue has been successfully launched on 1 January 2021.

Best Paper Awards

World Journal of Advance Healthcare Research (WJAHR)Honored the authors with best paper award, monthly based on the innovation of research work. Best paper will be selected by our expert panel.

Best Article of current issue

Download Article : Click here

Indexing

Abstract

OUTCOME OF IMMUNE THROMBOCYTOPENIC PURPURA (ITP). EXPERIENCE IN A TERTIARY CARE CHILDREN HOSPITAL OF BANGLADESH

*Md. Belayet Hossain and M. Selimuzzaman

ABSTRACT

Background: The pathogenesis of Childhood ldiopathic Thrombocytopenic Purpura(ITP), a common hematological disease involves antibody-mediated platelet destruction and reduced platelet production. Though in large number of cases it resolve spontaneously but we the pediatricians very frequently use steroid or IV Immunoglobulin due to lack of experience. Object: The objective of this study was to review the presenting features, natural history and remission rate of ITP cases spontaneously or to therapy. Method: This is a retrospective study conducted in the Department of Pediatric Haematology & Oncology of Dhaka Shishu (Children) Hospital during the period January 2018 to December 2019 and there was review and analysis of natural history and treatment response in children diagnosed with ITP age ranged of 9 months to 14 years. Results: Of 64 patient with ITP with a age range of 9 months to 14 years (mean age 6.1 ± 1.6 yrs) and female predominance 36 (56 %) female and 28 (44 %) male. Male female ratio was I: 1.3. Ten (15.6%) children had major hemorhage. The platelet counts were 6,000/cmm to 1.25,000/cmm (mean 19,000/cmm). Bone marrow study was done in 14 (22%) cases with no alteration in diagnosis. Regarding outcome, 25 (39%) patients had been achieved spontaneous remission and 39 (61%) needed intervention with corticosteroid. Among the patients treated with corticosteroid 26 (67%) patients responded to corticosteroid and 13 (33%) had gone to chronic stage. Out of 13 chronic ITP patients 6 had received Anti D Ig: of these 6 patients 100% patients maintained platelet count >30,000/cmm for variable periods, and 7 patients received oral Eltrombopag-a newer drug of ITP treatment: of these 7 patients 5(71%) had responded and maintaining platelet count >50,000/cmm for longer duration than Anti D and 2(29%) did not respond. These 13 of 64 (20%) patient remained as chronic ITP. Chronic ITP developed in older children. Conclusion: The overall prognosis in childhood ITP is excellent. Spontaneous remission occurred in good number of cases (39 %) and overall about 90% cases resolved with therapy or observation. Anti-D Immunoglobulin and Eltrombopag are promising in chronic ITP though further larger study is needed.

[Full Text Article]